Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis. Thromb Haemost. 2017 10 05; 117(10):1944-1951.
View in:
PubMed
subject areas
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Anticoagulants
Anticoagulants
Blood Transfusion
Blood Transfusion
Chi-Square Distribution
Chi-Square Distribution
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Gastrointestinal Hemorrhage
Gastrointestinal Hemorrhage
Hemorrhage
Hemorrhage
Humans
Humans
Intracranial Hemorrhages
Intracranial Hemorrhages
Logistic Models
Logistic Models
Male
Male
Middle Aged
Middle Aged
Odds Ratio
Odds Ratio
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
Vitamin K
Vitamin K
authors with profiles
Gary E Raskob